Replies to post #575563 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

I sold a huge amount of shares at $ 1.8 in 2021 just before ASM with an average of 45 cents
Then bought it back at 1.2 and averaged cost down to now $1

Im now on break even a little in the plus.

I know how crap management is. I decided to give it a rest, nothing will change rehashing that here over and over.

Where will patients go to find info about this therapy once approved by MHRA?

MD's worldwide will know about DCVAXL after being approved in the UK and redirect their patients for the simple reason that DCVAXL will be the only approved drug in a first-world country for GBM next to SOC. trust me on that one.